Evasin and TSLPI Tick Salivary Antigen Subunit Vaccine Nanoparticles Induce Humoral and Cellular Immunity

Evasin 和 TSLPI 蜱唾液抗原亚单位疫苗纳米颗粒诱导体液免疫和细胞免疫

阅读:1

Abstract

Tick-borne diseases have increased significantly due to several factors, including climate change. Ticks can carry diverse pathogens, and transmission is facilitated by immunosuppressive tick salivary proteins. Vaccination targeting tick salivary proteins has been proposed as a strategy to enhance broad acquired immunity against tick-borne pathogens. Given the immunosuppressive nature of these proteins, we leveraged the ability of nanoparticles to enhance antigen immunogenicity. We synthesized nanoparticles directly from tick salivary proteins, evasin-3 and tick salivary lectin pathway inhibitor (TSLPI), by desolvation with ethanol and cross-linking. Nanoparticles formulated with the CpG oligonucleotide adjuvant significantly enhanced both humoral and cellular immune responses against both evasin-3 and TSLPI in mice compared to soluble CpG adjuvanted antigens. These results demonstrate the importance of antigen delivery and presentation, particularly for poorly immunogenic antigens, and the potential for protein nanoparticles to be developed as vaccines against diverse tick-borne pathogens.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。